Product Information
YUPELRI 175 MCG/3 ML SOLUTION is a brand product labeled by Viatris Specialty LLC, priced at $17.4196 per ML under NDC 49502080693. Its NADAC has been published 357 times since Oct 23, 2019.
FDA first approved this application on Nov 9, 2018.
Strength
175 ug/3mL
Manufacturer
Viatris Specialty LLCNDC
49502080693
Classification
Brand
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
REVEFENACINApproval Type
New Drug (NDA)
FDA Application
NDA210598FDA Approved
11/9/2018
On Market Since
12/3/2018
Pharmacological Classes
Price Statistics
The NADAC for YUPELRI 175 MCG/3 ML SOLUTION has been published 357 times since Oct 23, 2019, and over the history we have for it it has risen 59.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.4196 per ML |
|---|---|
| All-time high | $17.4859 (May 13, 2026) |
| All-time low | $10.9503 (Oct 23, 2019) |
| 52-week high | $17.4859 |
| 52-week low | $16.5913 |
| Median price | $13.7879 |
| Average price | $13.9211 |
| Largest weekly change | +9.9% (Jul 10, 2024) |
| Weeks tracked | 357 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the revefenacin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of YUPELRI 175 MCG/3 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for YUPELRI 175 MCG/3 ML SOLUTION, manufactured by Viatris Specialty LLC, is $17.4196 per ML (NDC 49502080693), effective Aug 19, 2026.
How has the price of YUPELRI 175 MCG/3 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for YUPELRI 175 MCG/3 ML SOLUTION has risen 59.1%. It has been tracked across 357 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for YUPELRI 175 MCG/3 ML SOLUTION?
Since Oct 23, 2019, the NADAC for YUPELRI 175 MCG/3 ML SOLUTION has ranged from a low of $10.9503 (Oct 23, 2019) to a high of $17.4859 (May 13, 2026), with a median of $13.7879 per ML.
Are there cheaper alternatives to YUPELRI 175 MCG/3 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of YUPELRI 175 MCG/3 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures YUPELRI 175 MCG/3 ML SOLUTION?
YUPELRI 175 MCG/3 ML SOLUTION (NDC 49502080693) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.